AIM： To analyze the microbiota shift in the dista esophagus of Sprague-Dawley rats fed a high-fat diet. METHODS： Twenty Sprague-Dawley rats were divided into high-fat diet and normal control groups of 10 rats each. ...AIM： To analyze the microbiota shift in the dista esophagus of Sprague-Dawley rats fed a high-fat diet. METHODS： Twenty Sprague-Dawley rats were divided into high-fat diet and normal control groups of 10 rats each. The composition of microbiota in the mucosa from the distal esophagus was analyzed based on se- lective culture. A variety of Lactobacillus species were identified by molecular biological techniques. Bacterial DNA from Lactobacillus colonies was extracted, and 165 rDNA was amplified by PCR using bacterial uni- versal primers. The amplified 16S rDNA products were separated by denaturing gradient gel electrophoresis （DGGE）. Every single band was purified from the gel and sent to be sequenced. RESULTS： Based on mucosal bacterial culturing in the distal esophagus, Staphylococcus aureus was absent, and total anaerobes and Lactobacillus species were de- creased significantly in the high-fat diet group compared with the normal control group （P 〈 0.01）. Detailed DGGE analysis on the composition of Lactobacillus species in the distal esophagus revealed that Lactobacillus crispa- tus, Lactobacillus gasseri （L. gasser/] and Lactobacillus reuteri （L. reuterl] comprised the Lactobacillus species in the high-fat diet group, while the composition of Lactobacillus species in the normal control group consisted of L. gasseri, Lactobacillus jensenii and L. reuteri. CONCLUSION： High-fat diet led to a mucosal micro- flora shift in the distal esophagus in rats, especially the composition of Lactobacillus species.展开更多
The fat nano-emulsion, which has been used as a drug carrier, especially for the poorly water soluble drug, has drawn favorable attention recently. Ubenimex is a poorly soluble drug with no parenteral treatment availa...The fat nano-emulsion, which has been used as a drug carrier, especially for the poorly water soluble drug, has drawn favorable attention recently. Ubenimex is a poorly soluble drug with no parenteral treatment available for patients. This study was aimed at the manufacture of a ubenimex loaded fat nano-emulsion for intravenous delivery by SolEmuls~ technology. The formulation and the process parameters were optimized by single-factor design and the obtained ubenimex loaded fat nano-emulsion was stable even after autoclaving. The average particle size was near 200 nm with narrow size distribution and a negative zeta potential of -44 mV. The in vitro release behavior of ubenimex from the fat nano-emulsion could be described by the double phase kinetics model and expressed by the following equation： 100 - Q = 75.27e^-0.369t ＋ 15.94e^-0.0324t, Rα = 0.9863, Rβ = 0.9878. The pharmacokinetic study showed that the pharmacokinetic curves of both the ubenimex fat nano-emulsion and the i.v. ubenimex suspension, were similar and the main parameters showed no significant difference except t1/2. In conclusion, the fat nano-emulsion with ubenimex has potential as a safe and effective parenteral delivery system for poorly water soluble anti-cancer drugs.展开更多
文摘AIM： To analyze the microbiota shift in the dista esophagus of Sprague-Dawley rats fed a high-fat diet. METHODS： Twenty Sprague-Dawley rats were divided into high-fat diet and normal control groups of 10 rats each. The composition of microbiota in the mucosa from the distal esophagus was analyzed based on se- lective culture. A variety of Lactobacillus species were identified by molecular biological techniques. Bacterial DNA from Lactobacillus colonies was extracted, and 165 rDNA was amplified by PCR using bacterial uni- versal primers. The amplified 16S rDNA products were separated by denaturing gradient gel electrophoresis （DGGE）. Every single band was purified from the gel and sent to be sequenced. RESULTS： Based on mucosal bacterial culturing in the distal esophagus, Staphylococcus aureus was absent, and total anaerobes and Lactobacillus species were de- creased significantly in the high-fat diet group compared with the normal control group （P 〈 0.01）. Detailed DGGE analysis on the composition of Lactobacillus species in the distal esophagus revealed that Lactobacillus crispa- tus, Lactobacillus gasseri （L. gasser/] and Lactobacillus reuteri （L. reuterl] comprised the Lactobacillus species in the high-fat diet group, while the composition of Lactobacillus species in the normal control group consisted of L. gasseri, Lactobacillus jensenii and L. reuteri. CONCLUSION： High-fat diet led to a mucosal micro- flora shift in the distal esophagus in rats, especially the composition of Lactobacillus species.
基金Shandong Province Natural Science Foundation (Grant No.ZR2009CM011)
文摘The fat nano-emulsion, which has been used as a drug carrier, especially for the poorly water soluble drug, has drawn favorable attention recently. Ubenimex is a poorly soluble drug with no parenteral treatment available for patients. This study was aimed at the manufacture of a ubenimex loaded fat nano-emulsion for intravenous delivery by SolEmuls~ technology. The formulation and the process parameters were optimized by single-factor design and the obtained ubenimex loaded fat nano-emulsion was stable even after autoclaving. The average particle size was near 200 nm with narrow size distribution and a negative zeta potential of -44 mV. The in vitro release behavior of ubenimex from the fat nano-emulsion could be described by the double phase kinetics model and expressed by the following equation： 100 - Q = 75.27e^-0.369t ＋ 15.94e^-0.0324t, Rα = 0.9863, Rβ = 0.9878. The pharmacokinetic study showed that the pharmacokinetic curves of both the ubenimex fat nano-emulsion and the i.v. ubenimex suspension, were similar and the main parameters showed no significant difference except t1/2. In conclusion, the fat nano-emulsion with ubenimex has potential as a safe and effective parenteral delivery system for poorly water soluble anti-cancer drugs.
